We hope you all had a meaningful Christmas, despite the calamity which rendered thousands of our countrymen homeless, foodless, workless and uncertain of what the future holds for them. We
We share the optimism of Fr. Nicanor Austriaco Jr., OCTA research fellow, who reported during the President’s weekly “Talk to the People” that the Philippines appears to be attaining the
Nothing can be more frustrating for a physician than to be bluntly told by a recalcitrant smoker that “his spirit is willing but his flesh is weak.” In short,
On Nov. 25, the Concerned Doctors and Citizens of the Philippines (CDC PH) organized the first Philippine COVID summit to discuss pressing issues confronting us in the management of COVID-19.
Remember the warning in the old “Jaws” movies: “Just when you thought it was safe to go back in the water….” We’re all excited to enjoy the outside world, and
(Conclusion) In March, even before global scientists sounded the alarm on mass vaccination, we proposed to suspend the vaccination in 40-year-olds and younger, and in all healthy young adults, after
(First of two parts) On Oct. 15, the government began the vaccination for minors against COVID-19. We have extensively discussed the pros and cons of vaccinating adolescents and minors in
(Conclusion) In last week’s column, we discussed that ivermectin and molnupiravir may both be considered valuable additions to our early-treatment regimen for COVID-19. Despite the expected pricey cost of molnupiravir,
(First of two parts) In the past several days, some readers have asked us about the new antiviral drug molnupiravir, and how it compares with ivermectin. Last week, the United
(Conclusion) In last week’s column, we wrote about the amazing outcome many states in India like Uttar Pradesh and Delhi have attained with an ivermectin-based multidrug prevention and early treatment
The latest in global fashion, beauty, and culture through a contemporary Filipino perspective.
